• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

All Aboard

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 51-100 of 970 result(s).

Board Name	Posts By All Aboard	Post Created
GNBTQ Generex Biotechnology Corp.	Term sheets are usually "binding" o	06/25/2020 2:33:17 PM
GNBTQ Generex Biotechnology Corp.	The term sheet was voided by its te (1)	06/25/2020 2:10:09 PM
GNBTQ Generex Biotechnology Corp.	I would say this. This same investo	06/24/2020 2:14:02 AM
AMBS Amarantus Bioscience Holdings	We are listed as "STOP!" "Dark or d (2)	05/23/2020 4:21:46 PM
GNBTQ Generex Biotechnology Corp.	The N.Y. Supreme Court is the lowes	05/17/2020 2:02:16 AM
AMBS Amarantus Bioscience Holdings	Still waiting for the answer which	04/16/2020 11:08:20 PM
AMBS Amarantus Bioscience Holdings	Todos is doing a reverse split.	04/16/2020 1:55:33 PM
GNBTQ Generex Biotechnology Corp.	Remember, he is an absolute moron w (2)	03/18/2020 1:44:26 AM
GNBTQ Generex Biotechnology Corp.	We need a PR. Very odd we haven't s (1)	03/09/2020 6:19:33 PM
GNBTQ Generex Biotechnology Corp.	We should’ve had a press release	03/05/2020 10:56:47 AM
AMBS Amarantus Bioscience Holdings	https://www.otcmarkets.com/stock/E (2)	03/05/2020 10:16:32 AM
GNBTQ Generex Biotechnology Corp.	Interesting article on Epivax https	03/04/2020 1:35:11 PM
GNBTQ Generex Biotechnology Corp.	The whole FINRA "approval" process	02/22/2020 6:36:41 PM
AMBS Amarantus Bioscience Holdings	As much as I want this to work out	02/12/2020 12:15:05 PM
AMBS Amarantus Bioscience Holdings	The chart on pages 3 to 7 gives the (1)	02/11/2020 9:35:32 PM
AMBS Amarantus Bioscience Holdings	Again, Emerald is traded on the OTC (1)	02/11/2020 9:16:12 PM
AMBS Amarantus Bioscience Holdings	Emerald has a public float of only	02/11/2020 8:31:43 PM
AMBS Amarantus Bioscience Holdings	Great question for GC. I don’t se	02/11/2020 7:51:57 PM
AMBS Amarantus Bioscience Holdings	Emerald is an OTC stock and as such (1)	02/11/2020 10:34:37 AM
AMBS Amarantus Bioscience Holdings	Anyone have any thoughts on what wi (2)	02/10/2020 9:39:26 PM
AMBS Amarantus Bioscience Holdings	The stated reason was that Todos ap	02/09/2020 10:41:57 AM
AMBS Amarantus Bioscience Holdings	AMBS currently owns 80.01% of Break (1)	02/08/2020 1:09:07 PM
AMBS Amarantus Bioscience Holdings	Yeah, they have never explained how	01/30/2020 10:31:29 AM
AMBS Amarantus Bioscience Holdings	I don't think that is what Gerald m (3)	01/29/2020 2:49:49 PM
AMBS Amarantus Bioscience Holdings	Bart @canescru @G_Commish $Ambs any (4)	01/23/2020 3:58:45 PM
AMBS Amarantus Bioscience Holdings	For once, I hope they have made “ (2)	11/17/2019 11:13:11 PM
AMBS Amarantus Bioscience Holdings	It's an actual thing at least. 7-11 (1)	11/12/2019 8:02:07 PM
AMBS Amarantus Bioscience Holdings	Again, I don't understand what your	05/11/2019 9:43:56 PM
AMBS Amarantus Bioscience Holdings	This is music to my ears. I was rea	05/10/2019 8:53:12 PM
AMBS Amarantus Bioscience Holdings	Todos is presenting at this event i	05/06/2019 12:32:23 PM
AMBS Amarantus Bioscience Holdings	https://talkmarkets.com/content/st (2)	05/06/2019 12:21:50 PM
AMBS Amarantus Bioscience Holdings	We are late on our financial disclo	05/02/2019 10:06:52 PM
AMBS Amarantus Bioscience Holdings	Todos is presenting in Vegas in a f	05/01/2019 4:19:05 PM
AMBS Amarantus Bioscience Holdings	Maxim Group LLC is underwriting a p (3)	04/26/2019 5:40:52 PM
AMBS Amarantus Bioscience Holdings	https://talks.ox.ac.uk/talks/id/02 (1)	04/24/2019 11:09:41 AM
AMBS Amarantus Bioscience Holdings	article in the Jerusalem Post ... h (2)	04/19/2019 7:29:29 PM
AMBS Amarantus Bioscience Holdings	I also note that the Todos sharehol (2)	04/19/2019 2:24:23 PM
AMBS Amarantus Bioscience Holdings	On March 28, Todos announced their (1)	04/18/2019 2:35:02 PM
AMBS Amarantus Bioscience Holdings	I think it’s better to think in n (1)	04/13/2019 2:51:48 PM
AMBS Amarantus Bioscience Holdings	We licensed it and then dropped the (4)	04/13/2019 9:02:00 AM
AMBS Amarantus Bioscience Holdings	At least Psychogenics can't termina (1)	04/07/2019 4:03:17 PM
AMBS Amarantus Bioscience Holdings	Todos sent out a proxy asking share (5)	04/04/2019 2:55:10 PM
AMBS Amarantus Bioscience Holdings	Avant has a new video presentation (1)	04/03/2019 10:53:58 PM
AMBS Amarantus Bioscience Holdings	My tone is realism vs Pollyanna. Re (1)	03/31/2019 3:16:34 PM
AMBS Amarantus Bioscience Holdings	The PR made 4 references to the 1st (2)	03/30/2019 11:13:31 AM
AMBS Amarantus Bioscience Holdings	I seem to recall that in the last c	03/29/2019 1:32:25 PM
AMBS Amarantus Bioscience Holdings	Todos Medical to Present at Two Upc	03/28/2019 6:14:53 PM
AMBS Amarantus Bioscience Holdings	The Todos Medical shareholders are (2)	03/28/2019 6:13:13 PM
AMBS Amarantus Bioscience Holdings	From 2013: Amarantus Appoints Dr. C	03/27/2019 12:52:00 PM
AMBS Amarantus Bioscience Holdings	Looks like they changed the name of	03/26/2019 3:11:24 PM

• Next >

58067745806748580452857765685770083573785857372845706268569797556943795694313569357956831575673362567266356726535672613567258856718165671307566967256693535658909565795756525225594538559044454343905434039543001754300125428093542690954235555421296541846154183805417793541324154131295406755540401454029985398076539746853968225395976539597553942785393039

Recent Articles

• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
• Remitly to Showcase Innovations at Upcoming TMT Summit
• Dana Incorporates Leadership Change Amid Strategic Transformation
• Lexicon Pharmaceuticals Announces Upcoming December Investor Events
• Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
• NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
• ORIC Pharmaceuticals Enhances Visibility at December Conferences
• LanzaTech Welcomes Thierry Pilenko to Board of Directors
• Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
• EMP Metals Secures $3 Million Loan Agreement with Tembo
• Leslies Experiences Financial Challenges in Latest Earnings
• Dana Incorporates Strategic Changes to Boost Growth and Value
• Fluence Energy Delivers Impressive Q4 Results and Growth Insights
• StealthGas Reports Impressive Q3 Earnings Growth
• Analyzing PennantPark Floating Rate's Q4 Earnings Results
• Insights on Pennant Park Investment's Latest Earnings Report
• Central Garden & Pet Reports Improved Q4 Earnings Results
• Enanta Pharma Reports Strong Q4 Earnings Surprising Analysts
• Woodward's Impressive Earnings Surge: Insights and Guidance
• Blue Bird's Q4 Earnings Report: Insights and Analysis
• Overview of New Jersey Resources' Recent Earnings Report
• Central Garden & Pet Surprises Investors with Earnings Report
• Enanta Pharma Reports Promising Q4 Earnings Highlights
• Blue Bird Faces Earnings Challenge: A Detailed Overview
• Recent Trends in Russian Stock Market: Key Insights Revealed
• Leslie's Reports Fourth-Quarter Loss Driven by Rising Costs
• Brazil Stock Market Sees Positive Trends with Bovespa Rise
• Canadian Stock Market Analysis: Trends and Key Movers